Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BiondVax enrols first patient in phase 3 second cohort of M-001 flu vaccine
Image: BiondVax to enrol nearly 8,000 participants for the second cohort for the phase 3 trial of the M-001 vaccine candidate. Photo: courtesy of WikiImages/Pixabay.
Image: BiondVax to enrol nearly 8,000 participants for the second cohort for the phase 3 trial of the M-001 vaccine candidate. Photo: courtesy of WikiImages/Pixabay.